MNPR - Wall Street Estimates - Monopar Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 28.54

-6.36 %

$ 173 M

Market Cap

-14.41

P/E

Price Target Average

3.36%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

97.24%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Monopar Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for MNPR of $29.5 , with forecasts ranging from a low of $22 to a high of $37 .

MNPR Lowest Price Target Wall Street Target

22 USD -22.92%

MNPR Average Price Target Wall Street Target

29.5 USD 3.36%

MNPR Highest Price Target Wall Street Target

37 USD 29.64%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free